Note 19 - Subsequent Events (Details Textual) $ in Millions |
3 Months Ended |
|---|---|
|
Mar. 31, 2023
USD ($)
| |
| Amended and Restated Tilmanocept License Agreement [Member] | Forecast [Member] | |
| Increase (Decrease) in Accrued Liabilities, Total | $ 1.2 |
| X | ||||||||||
- Definition The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|